- Home
- EYPT vs HFRO Comparison
EYPT vs HFRO Comparison
Compare EYPT & HFRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- HFRO
- Stock Information
- Founded
- EYPT 1987
- HFRO 2000
- Country
- EYPT United States
- HFRO United States
- Employees
- EYPT N/A
- HFRO N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- HFRO Finance/Investors Services
- Sector
- EYPT Industrials
- HFRO Finance
- Exchange
- EYPT Nasdaq
- HFRO Nasdaq
- Market Cap
- EYPT 439.4M
- HFRO 402.7M
- IPO Year
- EYPT 2005
- HFRO N/A
- Fundamental
- Price
- EYPT $9.17
- HFRO $5.43
- Analyst Decision
- EYPT Strong Buy
- HFRO
- Analyst Count
- EYPT 8
- HFRO 0
- Target Price
- EYPT $27.29
- HFRO N/A
- AVG Volume (30 Days)
- EYPT 1.1M
- HFRO 421.7K
- Earning Date
- EYPT 11-07-2024
- HFRO 01-01-0001
- Dividend Yield
- EYPT N/A
- HFRO 12.00%
- EPS Growth
- EYPT N/A
- HFRO N/A
- EPS
- EYPT N/A
- HFRO 1.23
- Revenue
- EYPT $45,713,000.00
- HFRO $44,535,929.00
- Revenue This Year
- EYPT N/A
- HFRO N/A
- Revenue Next Year
- EYPT N/A
- HFRO N/A
- P/E Ratio
- EYPT N/A
- HFRO $5.50
- Revenue Growth
- EYPT 7.50
- HFRO N/A
- 52 Week Low
- EYPT $5.86
- HFRO $5.92
- 52 Week High
- EYPT $30.99
- HFRO $9.38
- Technical
- Relative Strength Index (RSI)
- EYPT 38.25
- HFRO 28.33
- Support Level
- EYPT $11.26
- HFRO $5.34
- Resistance Level
- EYPT $12.23
- HFRO $5.54
- Average True Range (ATR)
- EYPT 0.97
- HFRO 0.11
- MACD
- EYPT -0.30
- HFRO -0.00
- Stochastic Oscillator
- EYPT 3.24
- HFRO 20.27
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About HFRO Highland Opportunities and Income Fund of Beneficial Interest
Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. The company's portfolio of investments includes different industry investments such as Financial, Communication Services, Energy, Healthcare, Materials, and others.